Date: 2015-09-17
Type of information: Nomination
Compound:
Company: Osiris Therapeutics (USA - MD)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On September 17, 2015, Osiris Therapeutics, a cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced the appointment of Gregory Law , to serve as Chief Financial Officer and Dwayne Montgomery , to serve as Chief Business Officer.
Mr. Law has been employed with Osiris since 2014 as the Vice President of Finance and Principal Accounting Officer. Mr. Law has more than 25 years of finance and accounting experience in a variety of industries, including biotechnology, telecommunications, energy, private equity and consulting. Prior to joining Osiris in 2014, Mr. Law spent over a decade providing consulting services to public and private companies in the areas of interim CFO and controllership, financial reporting, mergers and acquisitions, valuation and compliance. Before his consulting career, Mr. Law held a number of increasingly responsible finance positions at various public companies, such as XO Communications , MCI and General Electric. He graduated from Virginia Tech with a B.S. in accounting and earned his M.B.A. from George Washington University . He is also CPA licensed in the state of Maryland .
Mr. Montgomery joined Osiris in April 2014 as General Manager for the Orthopaedics and Sports Medicine franchise. In his new role, Mr. Montgomery will be responsible for Global Business Development for all products. He will continue to manage the orthopaedics and sports medicine businesses and execute the commercial launches of BIO4™ and Cartiform® with Osiris' strategic partners Stryker and Arthrex.
Mr. Montgomery brings more than two decades of extensive medical device experience in global commercialization and strategic planning. Prior to joining Osiris, Mr. Montgomery served as a commercial executive for venture-backed organizations in the trauma and spine markets. These included the role of Senior Vice President Sales and Marketing for IlluminOss Medical as well as Vice President Commercial Operations for Baxano Surgical . Mr. Montgomery also held progressing roles of executive responsibility at Smith & Nephew, Inc. , serving as Vice President and General Manager for the Orthopaedic Global Trauma Business. He also held the role of Vice President Sales and Marketing for the Clinical Therapies Global Business, a division that eventually became Bioventus, Inc. Mr. Montgomery earned a B.S. in chemistry from the University of North Alabama and a M.B.A. from the Massey School of Business at Belmont University .
Financial terms:
Latest news:
